Rachel Lutz

In mice models of hemophilia A, a modified tobacco plant diet was effective at prohibiting the development of inhibitors, according to research published in the journal Blood.

Pharyngitis prediction rules are not as accurate at identifying group A streptococcus cases as previously thought, according to findings published in the Canadian Medical Association Journal.

Therapy prevents suicide and more attempts in patients who have previously attempted suicide, according to a study published in The Lancet Psychiatry.

Investigators believe they may have identified a potential "off switch" for pain, according to study results published in the journal Brain.

Spinal cord injury animal models were able to regain muscle function after a treatment with a peptide injection, according to study results published in Nature.

The FDA issued a safety warning for the MS drug Tecfidera after a patient died from a rare brain disease while taking no other medications.

A urine test to detect preeclampsia is being developed by a startup group at Yale University.

Prenatal and early infant exposure to air pollutants may be linked to developing autism, according to research presented at the American Association for Aerosol Research.

Research teams examining the safety and efficacy of zanamivir and oseltamivir for influenza treatment concluded they are not as effective as popularly believed.

The FDA has approved Rixubis for the treatment of hemophilia B in children, manufacturer Baxter International Inc. announced.

Inhibitor screening is important for all hemophilia patients, not just those at high risk, according to a study by the CDC.

Companies will use cell line development studies to determine where factor VIII manufacturing costs can be lowered without sacrificing efficacy.

Lung infection bacteria levels will be tested via blood samples in emergency department patients in a new study being conducted at the University of Pittsburgh Medical Center.

The symptoms of depression were reduced in mice models which had high levels of PGC-1a1 in their skeletal muscle.

The launch of MS Radio aims to spread information, host discussions, and present features for multiple sclerosis patients, caregivers, and clinicians.

After a period of 6 months from post herpetic neuralgia onset, patients often report chronic pain, according to a study conducted in Rome, Italy.

Researchers in Denmark have found that serotonin production contributes to muscle spasms in spinal cord injury and Parkinson's disease patients.

In diarrhea patients, a frozen capsule fetal microbiota transplantation treatment can be effective to eliminate symptoms.

Ann Romney announced the launch of a neurologic center in collaboration with Brigham and Women's Hospital in Boston, set to open in 2016.

Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.

Doses of prepared human placenta culture cells are safe for multiple sclerosis patients, according to a study published in Multiple Sclerosis and Related Disorders.

Omega-3 supplementation can help reduce behavioral issues in adolescents who may be particularly prone to oxytocin receptor gene methylation.

The autoimmune system may not be the primary location for multiple sclerosis development, according to a study published in Science Translational Medicine.

Treatment-resistant cases of trigeminal neuralgia may be treated with duloxetine, according to a new case study.

An Australian team of researchers injected 10 female neuropathic pain patients with stem cells, which were overall, well-tolerated, according to research published in the Journal of Pain Research.

Research indicates that Complex Regional Pain Syndrome may be caused by an immune deficiency, and not traumatic events, as previously thought.

Concussions that do not heal within 7-10-days may be associated with psychiatric disorders.

Women treated for depression with collaborative care showed fewer symptoms after treatment than women who received traditional care, according to a new study.

A meta-analysis of the effects of current attention-deficit/hyperactivity disorder drugs has led researchers to conclude black market doses are unsafe for adolescent consumers.